Japan, Stalled On Frontier Science Plan

Japan's effort to launch an international program in basic biological research has stalled again amid continued confusion over its specifics, according to U.S. and Japanese sources familiar with the project. The latest setback to the Human Frontier Science Program came earlier this month at the Venice economic summit, where Prime Minister Yasuhiro Nakasone had been expected to unveil an official proposal. Instead, final details of the program remain under wraps, and the seven leaders of major in

Written byAlan Engel
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

The latest setback to the Human Frontier Science Program came earlier this month at the Venice economic summit, where Prime Minister Yasuhiro Nakasone had been expected to unveil an official proposal. Instead, final details of the program remain under wraps, and the seven leaders of major industrial nations, in a single paragraph far down in the summit communiqué, issued only a general endorsement of the concept.

"We welcome the initiative of the Human Frontier Science Program," the document said, noting that the feasibility study by Japan "will be continued, and we would be pleased to be kept informed about its progress."

That progress has been fitful since early last year, when Japan's Ministry of International Trade and Industry (MITI) revealed its plan for an international program of basic research into human biological functions. After the Science and Technology Agency weighed in with its own proposal, Nakasone ordered MITI, STA, the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies